UPDATE 1-U.S. Supreme Court declines to hear biologic drug patent fight

WASHINGTON, Dec 12 (Reuters) - The U.S. Supreme Court on

Monday declined to hear a case over whether companies that make

copycat versions of biologic drugs must wait six months after

winning federal approval before bringing them to the market.

Read more